XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Collaborative Arrangements - Ridgeback Biotherapeutics LP (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Sales $ 16,112 $ 15,035 $ 31,887 $ 29,522  
Cost of sales 3,745 4,024 7,285 7,951  
Selling, general and administrative 2,739 2,702 5,221 5,182  
Other current assets 38,205   38,205   $ 32,168
Accrued and other current liabilities 14,712   14,712   15,766
Ridgeback Biotherapeutics LP | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Cost of sales 96 193 287 414  
Selling, general and administrative 16 24 32 51  
Research and development 7 10 2 26  
Other current assets 8   8   0
Accrued and other current liabilities 24   24   $ 113
Ridgeback Biotherapeutics LP | Lagevrio | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Sales $ 110 $ 203 $ 460 $ 595